Despite appearing in peptide-focused clinical practice discussions, 5-amino-1MQ is not a peptide it is a small molecule
intramuscular route: count injections given Visit 3 (week 26) Anamnesis: record lifestyle habits and use of alcohol Symptoms: if pathological at the first visit, record paresthesia, asthenia, loss or reduction of appetite, sadness or change in level of happiness, and concomitant pharmacological treatment Physical examination: if pathological at the first visit examine for Hunters glositis, positional and vibrational sensitivity Record concomitant treatment Request analyses to be performed one week before next visit: haemogram and serum vitamin B12 Questionnaire: EuroQoL-5D Assessment of adverse effects Therapeutic plan: patient in oral arm provision of medication
And, as we have seen above, most therapies focus on simply relieving symptoms and offering coping strategies rather than tackling the roots of the problem
There is no human trial of this exact combination, so the evidence here is built from studies on the individual components, most of it preclinical
Multivitamins (MODERATE EFFECT) A typical multivitamin contains: 6-25 mcg B12 (daily recommended intake is 2.4 mcg) Effect: Can increase serum B12 by 20-50 pg/mL if taken daily Stop 2-3 days before the test for accuracy 3